Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient Outcome

10 Dec 2019

Abstract excerpt

Recent advances in high-throughput molecular and multi-omics technologies have improved our understanding of the molecular changes associated with thyroid cancer initiation and progression. The translation into clinical use based on molecular profiling of thyroid tumors has allowed a significant improvement in patient risk stratification and in the identification of targeted therapies, and thereby better...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Glutathione Transferases and Polymorphisms
Share to Thyroid Cancer Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31835496
DOI: 10.3390/cancers11121988

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multi-omics Signatures and Translational Potential to Improve Thyroid Cancer Patient OutcomePMID 31835496Read ↗

Genomics and Multi-Omics to Guide Clinical Management in Thyroid CancerSemantic proximity Read ↗

Integrated metabolic and genetic analysis reveals distinct features of primary differentiated thyroid cancer and its metastatic potential in humansSemantic proximity Read ↗

Genomic and epigenomic profile of thyroid cancerSemantic proximity Read ↗

Holomics and AI-Driven Precision Oncology for Medullary Thyroid Carcinoma: Addressing Challenges of a Rare and Aggressive DiseaseSemantic proximity Read ↗

Integrative Multi-omics Analysis Reveals Different Metabolic Phenotypes Based on Molecular Characteristics in Thyroid Cancer.Semantic proximity Read ↗

Integrated proteogenomic characterization of medullary thyroid carcinomaSemantic proximity Read ↗

Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risksSemantic proximity Read ↗

Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approachesSemantic proximity Read ↗

The Genomic Landscape of Thyroid Cancer Tumourigenesis and Implications for Immunotherapy.Semantic proximity Read ↗

Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risksSemantic proximity Read ↗

Recent Improvements in Genomic and Transcriptomic Understanding of Anaplastic and Poorly Differentiated Thyroid Cancers.Semantic proximity Read ↗

Multi-omics clustering analysis carries out the molecular specific subtypes of thyroid carcinoma: implicating for the precise treatment strategiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.